The Latin Trade Group will provide Chinese companies a chance to learn about investing and trading in Latin America and the Caribbean at the Sino Americas Intensive in Beijing on Nov. 10.
The free, invitation-only trade briefing will allow Chinese companies to learn about investment opportunities in Latin America's key sectors of energy, infrastructure and agribusiness.
“We want to steer the conversation directly into business,” Latin Trade Groups CEO Rosemary Winters said. “Tell the real story, with its good and bad sides, but highlighting that there are significant winnings to be made for companies that take the time to understand their counterpart on the other side of the Pacific."
The first half of the conference will offer expert insights from high-level public and private sector leaders on what Chinese companies need to succeed in Latin America and the Caribbean. The second half of the day will allow leader-to-leader networking and offer a space to market potential projects.
The Sino Americas Intensive is being held in partnership with the Hogan Lovells law firm, the Inter-American Development Bank and the Inter-American Dialogue. It will be held at the Beijing offices of Hogan Lovells International.
Organizations in this Story
Want to get notified whenever we write about Latin Trade Group ?
Next time we write about Latin Trade Group, we'll email you a link to the story. You may edit your settings or unsubscribe at any time.Sign-up for Alerts
- New Colombia Resources says Sannabis test was successful
- Grupo Exito aims to help support Colombia
- Codelco CEO calls for transparency, focus on production goals
- BCP offers tips on choosing master's degree program
- General Tire launches new tire for Andean market
- Latin America talks of boosting pork production, exports @CorferiasBogota
- AIR Worldwide team takes part in wind-engineering conference
- El Salvador's Asesuisa discusses risk management, strategic direction with stakeholders
- Grupo Exito buying lettuce locally to support resocialization program
- Endo selling Mexico-based Grupo-Farmaceutico Somar